United States · Series B startup

Who invested in Sudo Biosciences

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$30Mraised across 1 round since 2024, from 1 source

Latest round
Series B, $30MFeb 2024
Investors
2
See who backed them

The rounds

  1. Feb 2024
    Series B$30M

    Source recordedSEC filing: $64M sold, first sale Dec 2023

Founders and team

From Sudo Biosciences's own website and the SEC filings it signed: 4 on the team.

  • Scott ByrdChief Executive Officer
  • Roy GrayVice President, Non-Clinical Development
  • Dave JohnsonDirector
  • Terrie Walker-SmithBoard of Directors

On the board, as filediChris GagliardiDaniel EstesDavid JohnsonEdd FlemingShinichiro Fuse

Everyone who backed them

TPGPrivate equity1round
SanofiInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Sudo Biosciences

Who invested in Sudo Biosciences?

Sudo Biosciences's investors include TPG and Sanofi.

How much has Sudo Biosciences raised?

Sudo Biosciences has raised $30M across 1 round since 2024.

When did Sudo Biosciences last raise?

Sudo Biosciences's most recent round was a Series B of $30M in Feb 2024.

What was Sudo Biosciences's biggest round?

Its most recent round, $30M in Feb 2024, is also its largest on record.

Who backed Sudo Biosciences first?

Sudo Biosciences's first round on record, in Feb 2024, was backed by TPG and Sanofi.

What stage is Sudo Biosciences at?

Sudo Biosciences's latest named round is a Series B, in Feb 2024.

Where is Sudo Biosciences based?

Sudo Biosciences is based in the United States.

Companies like Sudo Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.